RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$973M
AUM Growth
+$326M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1
+$68.6M
2
+$61.6M
3
+$52.2M
4
RPRX
Repros Therapeutics Inc.
RPRX
+$25.5M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$18.8M

Top Sells

1
+$22.4M
2
+$11.5M
3
+$8.32M
4
ENZ
Enzo Biochem, Inc.
ENZ
+$6.62M
5
NVAX icon
Novavax
NVAX
+$3.96M

Sector Composition

1 Healthcare 84.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$5.57M 0.4%
527,797
-133,899
27
$5.55M 0.4%
199,398
28
$5.26M 0.38%
+44,444
29
$4.54M 0.33%
20,417
30
– –
0
31
– –
0
32
– –
0
33
– –
0
34
– –
-2,268,653
35
– –
0
36
– –
-666,667
1
2